Introduction
Human embryonic stem cells (hESCs) are pluripotent cells with the properties of self-renewal and differentiation potential into various cell types, including cardiovascular progenitor cells (CVPCs [1] [2] [3] [4] ). This in vitro differentiation system provides unique tools for the study of early cardiovascular development [5] , drug screening [6, 7] , cytotoxicity testing [8, 9] , and cardiac regenerative therapy [10, 11] . However, the physiological and pharmacological properties of hESCs and CVPCs, such as the Ca 2+ signaling and the response to various modulators, are largely unknown. Such knowledge will promote the pharmacological regulation of lineage-specific commitment, the quality control of hESC derivatives from functional perspectives, and subsequently benefit the preclinical and clinical study of these cells.
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Nucleotides, such as ATP, have been shown to play a fundamental role in the cardiovascular system under physiological and pathological conditions through the activation of specific purinergic receptors [12] [13] [14] . Extracellular nucleotide-activated membrane P2 receptors (P2Rs) are composed of seven mammalian P2X receptors (P2XRs) acting as Ca 2+ channels and eight mammalian P2Y receptors (P2YRs) coupling to G proteins [15] . Both P2XRs and P2YRs are widely expressed in early developing embryos, suggesting that they may play roles in various cell types [16] . However, little is known about the difference of P2R subtype-mediated Ca 2+ signals between the hESCs and CVPCs, a gap for the application of these cells in drug development and cytotoxicity testing.
P2R activation-mediated Ca 2+ signals have been shown to regulate the physiological responses in the cardiovascular system, such as endothelial cells [17, 18] , smooth muscle cells [19, 20] , and cardiomyocytes [21, 22] . They are also involved in the proliferation and cardiac differentiation of mouse (m) ESCs [23, 24] and the growth of human adult cardiac progenitors [25] . In addition, G protein-mediated Ca 2+ signals play a role in the maintenance of undifferentiated state of hESCs [26] . ATP has been verified to induce Ca 2+ transients in hESCs and derived cardiomyocytes [27] . However, the contribution of P2Rs to extracellular nucleotide-mediated Ca 2+ signals in the hESCs and the derived CVPCs is largely unknown.
The activation of G q/11 -protein coupled P2YR subtypes elicits intracellular Ca 2+ release via inositol 1,4,5-trisphosphate receptors (IP 3 Rs) on the endoplasmic reticulum [28] . IP 3 Rs consist of three subtypes, termed IP 3 R1, IP 3 R2, and IP 3 R3, and have a tissue-specific distribution relating to their physiological and pharmacological responses in various tissues [29, 30] , including cardiovascular systems [31] [32] [33] . However, the roles and the functional coupling of P2Rs and IP 3 R subtypes in hESCs and derived CVPCs remain unclear.
Thus, the aims of this study are to determine (i) the expression pattern of P2Rs and IP 3 Rs in hESCs and derived CVPCs; (ii) the Ca 2+ responses of these cells to multiple extracellular nucleotides (ATP, UTP, ADP, and UDP) and P2R-targeted reagents; and (iii) the contribution of IP 3 R subtypes to P2R-mediated Ca 2+ signals.
Methods hESC culture and CVPC induction
hESC culture and CVPC induction were carried out as described previously [4, 34] . 2+ imaging. To reduce apoptosis, 5 mM Rock inhibitor Y27632 (Stem Cell Technologies, Vancouver, Canada) was added for the first 24 h after cell seeding. The embryoid body (EB) differentiation assay was performed according to the previous report [35] .
Immunostaining
Immunostaining assays were performed as previously described [34] . Briefly, cells were fixed with 4 % paraformaldehyde and permeabilized in 0.3 % Triton X-100 for intracellular antigens (Sigma, Saint Louis, MO, USA), blocked in 10 % normal goat serum (Vector Laboratories, Burlingame, CA, USA) and then incubated with primary antibodies against MESP1 (1:100; Aviva Systems Biology, San Diego, CA, USA), MEF2C (1:100; Cell Signaling Technology, Danvers, MA, USA), ISL1 (1:100; Developmental Studies Hybridoma Bank, Iowa City, IA, USA), Oct4 (1:200; Abcam, Cambridge, UK), or SSEA4 (1:100; Millipore, Temecula, CA, USA) at 4°C overnight and detected by DyLight 488-or 549-conjugated secondary antibodies (Jackson ImmunoResearch Laboratories, West Grove, PA, USA). Nuclei were stained with DAPI (Sigma, Saint Louis, MO, USA). A Zeiss Observer microscope was used for slide observation and image capture.
Flow cytometry analysis
Cells were harvested and dissociated by Accutase (Stem Cell Technologies, Vancouver, Canada). Samples were blocked by 3 % fetal bovine serum and then stained for the presence of appropriate hESCs or CVPCs markers using antibodies including PE-conjugated SSEA1 (1:20; eBioscience, San Diego, CA, USA), PE-conjugated SSEA4 (1:100; BD Biosciences, San Jose, CA, USA), and un-conjugated SOX2 (1:100; R&D Systems, Minneapolis, MN, USA) with PEconjugated secondary antibody (1:200; eBioscience, San Diego, CA, USA) or isotype-matched negative controls.
Ca
2+ imaging hESCs or CVPCs were loaded with 2.5 μM Fluo4-AM (Life Technologies, South San Francisco, CA, USA) dissolved in the extracellular bath solution for 30 min at 37°C [27] . Then the Ca 2+ indicator was washed out for three times by the bath solution and the cells were used 30 min later at room temperature for the de-esterification of the dye. The fluorescence of hESCs or CVPCs was measured using a confocal laser scanning microscope (LSM 710, Carl Zeiss, Oberkochen, Germany) with a ×20 objective. The fluorescence intensity was excited with wavelength 488 nm and the emission was collected with wavelength >493 nm. Images were acquired every 2 s.
Analysis of Ca 2+ responses
The analysis of Ca 2+ responses was based on the customermodified Interactive Data Language (IDL, ITT corporation, White Plains, NY, USA) Program, Flash Sniper reported previously [36] . Briefly, the images recorded were opened by Flash Sniper and a mask was set up to exclude the noise signals from non-cell regions. The region of interest (ROI) was manually selected for each cell. The normalized amplitude of a Ca 2+ transient was expressed as dF/F 0 = (F 1 − F 0 )/F 0 , where F 0 and F 1 are the values of the fluorescence at rest and the peak time point, respectively. For each ROI, the start-time and end-time of Ca 2+ transients were set manually and dF/F 0 was calculated by Flash Sniper. Finally, the traces representing the fluorescence changes were automatically generated by the software. The cell with dF/F 0 > 0.2 was defined as a responding cell. For the calculation of amplitude values, the counted cell number of randomly selected responding cells in each field is commonly >50, while all the responding cells were chosen when the total responding cell number is <50 in the experiment with some reagents. All the cells in each field of imaging were counted for calculating the responding percentage. The responding cell percentage was calculated as responding cell number/total cell number examined. At least three independent experiments were done for each concentration of the reagents.
Reverse transcription (RT)-PCR and quantitative real-time PCR (Q-PCR)
Total RNA was prepared using an RNeasy Plus Mini Kit (QIAGEN, Hilden, Germany) following the manufacturer's instructions and treated with RNase-Free DNAse (Promega, Madison, WI, USA) for 15 min to eliminate the potential contamination of genomic DNA. cDNAs were generated by reverse-transcribed total RNA (1 μg) using ReverTra Ace reverse transcriptase (Toyobo, Osaka, Japan). The RT-PCR was carried out using 2× Taq Plus Master Mix (Vazyme, Piscataway, NJ, USA). GAPDH was used as endogenous control, and samples without reverse transcription were used as negative controls. Q-PCR was performed and analyzed by the ViiA™ 7 Real-Time PCR System (Life Technologies, Carlsbad, CA, USA) with SYBR Green Q-PCR Master Mix (Toyobo, Osaka, Japan). Q-PCR data were expressed as fold changes normalized to internal control GAPDH. The RT-PCR and Q-PCR primers were selected from the Primer Bank and were listed in Supporting Information Table S1 . . Single clones were picked out and amplified. Two clones of IP 3 R3KD from either H9 (siIP 3 R3-1 and siIP 3 R3-2) or H7 (siIP 3 R3-a and siIP 3 R3-b) hESCs were used in this study.
Western blot analysis
Total membrane fractions of hESCs and CVPCs were prepared as previously reported [24] and were separated on 8 % SDS-PAGE gels and transferred to Nitrocellulose Blotting Membranes. The antibodies against IP 3 R1 and IP 3 R2 were made as previously reported [38] . The antibodies against IP 3 R1 (1:1000), IP 3 R2 (1:1000), IP 3 R3 (1:1000; BD Biosciences, San Jose, CA, USA), and β-actin (1:8000; Sigma, Saint Louis, MO, USA) were used. Then the membranes were incubated with IRDye 680LT Donkey anti-Rabbit IgG or IRDye 800LT Donkey anti-mouse IgG (1:8000; Li-COR Biosciences, Lincoln, NE, USA) as secondary antibodies and visualized on an Odyssey Infrared Imager (Li-COR Biosciences, Lincoln, NE, USA).
Reagents and solutions
(N)-Methanocarba-2-MeSADP (MRS2365), 2-methylthio-ATP ( 2-M eSATP), and 2-chlor o-N 6 -methyl -(N )-methanocarba-2′-deoxyadenosione-3′,5′-bisphosphate (MRS2279) were purchased from Tocris Biosciences Ltd (Bristol, UK). All the other reagents, including ATP, UTP, ADP, UDP, 2′(3′)-O-(4-Benzoylbenzoyl)-ATP (BzATP), pyridoxal phosphate-6-azophenyl-2′,4′-disulfonic acid (PPADS), suramin, and 2-aminoethoxydiphenyl borate (2-APB) were purchased from Sigma (Saint Louis, MO, USA). Reagents were all directly dissolved in distilled water except PPADS and 2-APB which were dissolved in DMSO. The extracellular bath solution contains (in mM) NaCl, 135; KCl, 5.4; CaCl 2 1.8; MgCl 2 1.0; glucose, 10; and HEPES, 10 (pH adjusted to 7.4). For Ca
2+
-free solution, extracellular CaCl 2 was removed and 1 mM EGTA was added.
Statistical analysis
The data were presented as means ± SEM. 50 values of the concentration-response curves were calculated using nonlinear regression (variable slope), and the slopes of concentration-amplitude curves were calculated using linear regression. All the statistical analyses were performed by GraphPad Prism5 (San Diego, CA, USA). P < 0.05 was considered statistically significant.
Results

Differential Ca
2+ responses to the P2R stimulation in hESCs and derived CVPCs H9 and H7 hESCs had typical morphology and pluripotent characteristics, such as alkaline phosphatase activity (ALP, Fig. 1a ) and the expression of pluripotent markers SSEA4 and SOX2 (Fig. 1b) , while the derived CVPCs expressed ISL1/MESP1/MEF2C/SSEA1 (Fig. 1c) as previously reported [4, 34] .
To determine the function of P2Rs in hESCs and derived CVPCs, we measured intracellular Ca 2+ responses to various nucleotides in these cells. hESCs and CVPCs showed different responding patterns of intracellular Ca 2+ activities to extracellular nucleotides in a concentration-dependent manner. UTP, a P2Y 2,4 receptor agonist [39] , up to 300 μM only induced Ca 2+ signals in 34.6 ± 6.3 % (H9) and 18.4 % ± 3.4 % (H7) of hESCs but in almost all CVPCs (Fig. 2a, b) , while the non-specific P2R agonist ATP (100 μM) triggered intracellular Ca 2+ responses in almost all hESCs and CVPCs (Fig. 2a, c) .
The concentration-response curves for UTP (Fig. 2b) and ATP (Fig. 2c ) significantly shifted to left in the CVPCs compared with those in the hESCs, indicating that the CVPCs are more sensitive to UTP and ATP than hESCs. The EC 50 values of UTP were more than 40-fold higher in hESCs than those in CVPCs (Fig. 2b) . The EC 50 values of ATP were more than ninefold higher in hESCs than those in CVPCs (Fig. 2c) . Moreover, the amplitude of Ca 2+ transients induced by UTP or ATP was concentration-dependently increased in both hESCs and CVPCs, but the amplitude was significantly higher in the CVPCs than in the hESCs (Fig. 2d, e) . Further, the slopes of concentration-amplitude curves to UTP in CVPCs were nearly twofold higher than those in hESCs (Fig. 2d) , while those to ATP were slightly higher in CVPCs than in hESCs (Fig. 2e) .
ADP, a P2Y 1,12,13 receptor agonist [39] , at 100 or 500 μM induced the Ca 2+ responses in most hESCs and CVPCs (Fig. 3a) . However, hESCs showed higher Ca 2+ responding percentage than that of CVPCs at lower concentration of ADP (10 μM, Fig. 3b ). There is no Ca 2+ response to UDP (up to 500 μM), a P2Y 6 receptor agonist [39] , in hESCs (Fig. 3c, d ), while CVPCs were concentration-dependently activated by UDP (Fig. 3d ).
These results demonstrate that the hESCs, at least H7 and H9 cell lines, and their derived CVPCs respond different Ca 2+ activities to extracellular nucleotides. Especially, CVPCs have significantly higher sensitivity and amplitude of Ca 2+ transients responding to UTP and ATP comparing with the hESCs.
Gene expression patterns of P2Rs and IP 3 Rs in hESCs and CVPCs
To determine whether the different nucleotide-induced Ca 2+ activities between hESCs and CVPCs are related to the transition of P2Rs, we analyzed their gene expression patterns. RNA samples from day 18 EBs differentiated from hESCs were used as positive controls. The expression of P2RX2, P2RX5, P2RX7, P2RY1, P2RY2, P2RY6, and P2RY12 was detected in both H9 and H7 hESCs (Fig. 4a) . The expression patterns of P2Rs were different in the CVPCs. P2RX1, P2RX2, and P2RX6 were hardly detected, while P2RX3 and P2RX4 were increased but P2RX5 and P2RX7 were decreased in the CVPCs compared with the hESCs (Fig. 4a) . Q-PCR analysis further confirmed the significantly lower expression levels of P2RX2, P2RX5, and P2RX7 and higher expression levels of P2RX3 and P2RX4 in the CVPCs than in the hESCs (Fig. 4b) . The expression of most P2RY genes were 7-fold to 60-fold higher in the CVPCs than those in the hESCs, including those hardly detected in the hESCs, such as the genes encoding P2Y 4,11,14 receptors (Fig. 4a, b) . In contrast, only the expression of P2RY1 was reduced by 75 % in the CVPCs compared with that in the hESCs (Fig. 4b) . These data indicate the transition of P2R gene expression patterns between the hESCs and CVPCs.
Because some P2YRs elicit Ca 2+ release from intracellular Ca 2+ store via activating IP 3 Rs [39] , we then compared the expression of three genes encoding for IP 3 R subtypes [29, 40] . It is noteworthy that the expression levels of all three ITPRs encoding IP 3 Rs were significantly lower in CVPCs than in hESCs (Fig. 4a, c) -free solution to block the Ca 2+ entry through membrane P2XRs [41] as shown in Fig. 5a . The extracellular Ca 2+ -free condition did not significantly alter the percentage of cells responding to ATP and only slightly decreased the amplitude of Ca 2+ transients in H9 hESCs and derived CVPCs (Fig. 5b-d) , indicating that little effects of P2XRs are involved. Then suramin, a nonselective antagonist of P2Rs except P2Y 4 receptor, and PPADS, a nonselective antagonist of most P2XRs and P2Y 1,4,6,13 receptors [42] , were applied to detect the involvement of P2YRs (Fig. 5a) . Pretreatment of 100 μM suramin or 50 μM PPADS reversibly blocked almost all the Ca 2+ events induced by ATP in hESCs ( Fig. 5b-d ). In contrast, they only partially inhibited the proportion of Ca 2+ responding cells (Fig. 5c ) and the amplitude of Ca 2+ transients (Fig. 5d ) in the CVPCs, even up to 200 μM suramin or 100 μM PPADS (data not shown). Similar results were observed in H7 hESCs and CVPCs (Online Resource Fig. S2 ). These results suggest that distinct P2YR subtypes regulate Ca 2+ signals in hESCs and derived CVPCs, while the contribution of P2XRs is trivial.
Since IP 3 Rs were the critical downstream mediators of the G q/11 -coupled P2Y 1,2,4,6,11 receptors [39] , we then examined whether IP 3 Rs were involved in the ATP-induced Ca 2+ activities. The IP 3 R inhibitor 2-APB at 100 μM [43] did not affect the baseline of Ca 2+ signals in H9 hESCs and CVPCs (Fig. 5b) , while it completely and reversibly inhibited the percentage of ATP-activated Ca 2+ events in the hESCs and largely attenuated the proportion of Ca 2+ responding CVPCs by about 90 % (Fig. 5c ) accompanied with a significant decrease of the amplitudes of Ca 2+ transients (Fig. 5d) . Similar results were observed in H7 hESCs and derived CVPCs (Online Resource Fig. S2 ). These results suggest an important role of IP 3 Rs in the generation of P2YR-mediated Ca 2+ signals following the ATP stimulation in both hESCs and CVPCs. Fig. 1 The maintenance of hESCs and directed differentiation to CVPCs. a Morphology and alkaline phosphatase (ALP) activity of H9 and H7 hESCs on day 2 and day 6 after passage. Scale bar, 100 μm. [46] ). Firstly, the ATP-induced Ca 2+ transients in hESCs were blocked by pre-incubation of 20 μM MRS2279 (Fig. 6a, b) but were not affected in CVPCs (Fig. 6c, d ). MRS2279 preincubation decreased the percentage of responding cells to ATP by 91 % in H9 and 82 % in H7 hESCs compared with ATP alone but it was ineffective in CVPCs (Fig. 6e) . Secondly, 2-MeSATP (50 μM) induced Ca 2+ transients in more than 90 % hESCs, and these responses were almost completely blocked by MRS2279 (20 μM) (Fig. 6a, b, f) . These data further confirmed that the function of P2XRs is trivial in hESCs. In contrast, only few CVPCs responded to 2-MeSATP (100 μM) stimulation (Fig. 6g) . Thirdly, MRS2365 (50 μM), a P2Y 1 receptor selective agonist, induced Ca 2+ transients in almost all hESCs (Fig. 6a, b, h ), while no responses to MRS2365 were detected in the CVPCs up to 100 μM (Fig. 6c, d, h ). Thus, P2Y 1 receptors appear to be a dominant P2R subtype in hESCs but not in CVPCs.
P2Y 1 receptor-mediated Ca 2+ activities through IP 3 R2 in hESCs
To identify the downstream IP 3 Rs in the P2Y 1 receptoractivated Ca 2+ signals in hESCs, we used downregulation and loss of function strategies. Since IP 3 R1 was hardly detected at protein level in hESCs (Fig. 7a) , we then examined the involvement of other two subtypes by establishment of IP 3 R2KO and stable IP 3 R3KD hESCs (Online Resource  Fig. S1a, b) . TALEN-mediated IP 3 R2KO and shRNAmediated IP 3 R3KD (siIP 3 R3) were confirmed by Western blot analysis (Fig. 7a, b) . These cells showed pluripotent markers and ALP activity similar to the vector control and WT hESCs (Online Resource Fig. S1c) . The P2Y 1 receptor-specific agonist MRS2365 concentration-dependently triggered Ca 2+ responses in WT and vector control hESCs (Fig. 7c, d ). These responses were not significantly altered in IP 3 R3KD hESCs (Fig. 7c, d ) but were rightward and downward shifted in IP 3 R2KO cell lines (Fig. 7d) . These data reveal that IP 3 R2 plays an important role in P2Y 1 receptor-mediated Ca 2+ activities in hESCs.
Differential coupling of IP 3 R3 and IP 3 R2 to ATPand UTP-targeted P2YRs in CVPCs
Due to the negligible function of P2Y 1 receptor in CVPCs, the coupling of IP 3 R2 and IP 3 R3 to other P2YR-mediated Ca 2+ signals in the CVPCs was examined. Our results showed that IP 3 R3KD or IP 3 R2KO hESC-derived CVPCs had comparable expression of CVPC marker SSEA1 between vector control and WT CVPCs (Online Resource Fig. S1d, e) . IP 3 R3KD did not alter the concentration-response curves of ATP in CVPCs (Fig. 7e, f) , but right-shifted the curves of UTP (Fig. 7g, h) , with the EC 50 values 7-fold to 9.5-fold (siIP 3 R3-1/2) and 3.5-fold to 7-fold (siIP 3 R3-a/b) higher than those of vector control CVPCs (Table 1) . However, IP 3 R2KO right-shifted the concentration-response curves of both ATP (Fig. 7i) and UTP (Fig. 7j) . The EC 50 values of ATP were 17-fold (IP 3 R2KO-6) and 12-fold (IP 3 R2KO-12) higher than those of WT CVPCs, and the values of UTP were 38-fold (IP 3 R2KO-6) and 17-fold (IP 3 R2KO-12) higher than those of WT CVPCs (Table 1 ). In addition, the slopes of the curves were decreased in the IP 3 R2KO CVPCs (Table 1) . Furthermore, the averaged amplitudes of Ca 2+ transients induced by ATP (300 nM to 10 μM) and UTP (100 nM to 3 μM) were decreased in IP 3 R2KO CVPCs compared with those in WT CVPCs (Online Resource Fig. S3 ). These results suggest that both IP 3 R2 and IP 3 R3 contribute to the UTP/P2Y 2,4 -mediated Ca 2+ activities in the CVPCs, while ATP/P2YR-mediated Ca 2+ signals are more dependent on the IP 3 R2 in these cells.
Discussion
The main findings of the present study are that (i) extracellular nucleotides elicit distinct intracellular Ca 2+ responses between hESCs and derived CVPCs, with more sensitive and stronger Ca 2+ responses to ATP and UTP in CVPCs than those in hESCs; (ii) the expression of most genes encoding P2YRs except P2Y 1 receptors are higher in the CVPCs than those in the hESCs; (iii) P2Y 1 receptors primarily mediate nucleotideinduced Ca 2+ activities in hESCs but not in CVPCs; and (iv) the different functional coupling between the P2YR subtypes and IP 3 R subtypes contributes to the distinct intracellular Ca 2+ signals in hESCs and CVPCs. These findings provide new insights into the physiological and pharmacological properties of hESCs and derived CVPCs by revealing critical roles of P2YRs and contributions of IP 3 R subtypes in the regulation of Ca 2+ signals via purinergic signaling pathways. Here, we detect the previously unrevealed contribution of P2R subtypes to Ca 2+ responses in hESCs, though ATP, the nonselective agonist of P2Rs, has been found to be involved in the Ca 2+ responses in mESCs [43] and hESCs [27] . In this study, we reveal that UTP and ADP but not UDP also trigger Ca 2+ activities in hESCs. In contrast, all the nucleotides tested induce robust Ca 2+ signals in the CVPCs. Moreover, distinct patterns of Ca 2+ responses to these nucleotides are observed between the hESCs and CVPCs. The Ca 2+ responses to ATP and UTP are more sensitive and stronger in the CVPCs than those in the hESCs, which may explain the recent finding that ATP treatment enhances cardiogenesis during mESC differentiation [23] . The differences could be interpreted by the distinct gene expression levels and selectivity of P2R subtypes in these cells (Fig. 4) . Notably, only part of hESCs respond to UTP (Fig. 2b) , a P2Y 2,4 receptor selective agonist [39] . Considering the correlation of cell surface proteins and pluripotency within hESCs [47] , it is worthy to further investigate the physiological relevance of the UTP responding hESC subpopulation on the self-renewal and differentiation. The Ca 2+ signals mediated by the P2XR activation are observed in various cell types [48, 49] . The P2rx3 and P2rx4 genes are expressed in mESCs [24] . In our study, the gene expression of P2RX2, P2RX5, and P2RX7 are detected in hESCs and P2RX3 and P2RX4 are detected in CVPCs (Fig. 4a) . However, P2XRs seem to play a limited role in the Ca 2+ responses of hESCs and CVPCs. This is supported by the following observations: (i) the responsive cell proportion remains unchanged in hESCs and CVPCs by removing extracellular Ca 2+ which blocks the P2XR-mediated Ca 2+ entry; (ii) almost no responses are detected in hESCs when triggered by the P2XR and P2Y 1 receptor nonselective agonist 2-MeSATP at the presence of P2Y 1 receptor selective antagonist MRS2279 (Fig. 6f) and few responses are triggered by 2-MeSATP in CVPCs (Fig. 6g) ; (iii) no responses are induced by the P2X 7 receptor agonist BzATP (data not shown) in hESCs and CVPCs. In contrast, the P2Y receptor agonists, such as ADP, UDP, UTP, and MRS2365, trigger distinct Ca 2+ responses between hESCs and CVPCs, suggesting the important role of P2YR during the transition of hESCs to CVPCs (Fig. 3b) . Taken together, our data here extend the previous findings by showing that the P2YRs but not P2XRs play crucial roles in nucleotide-mediated Ca 2+ signals in hESCs and CVPCs. This is further confirmed by the inhibitory effect of 2-APB, an IP 3 R antagonist [43] , on the ATP-mediated Ca 2+ signals in both cell types, suggesting the Ca 2+ responses are mediated by P2YR-IP 3 R coupling (Fig. 5c) .
Notably, the contributions of P2YR subtypes are different between hESCs and CVPCs. Among most of the eight P2YR subtypes, P2Y 1 receptors predominantly mediate Ca 2+ responses in the hESCs but not in the CVPCs. This is supported by the following evidence: firstly, P2Y 1 is the only P2YR subtype significantly reduced in the CVPCs compared with the hESCs (Fig. 4a, b) ; and secondly, the P2Y 1 receptor agonist MRS2365 [46] elicits Ca 2+ transients in most hESCs. Meanwhile, the majority of the hESCs responding to ATP and 2MeSATP are blocked by MRS2279, a P2Y 1 receptor-specific antagonist [46] . Therefore, P2Y 1 receptors dominantly contribute to nucleotide-induced Ca 2+ signals in the hESCs. Since the activation of P2Y 1 receptors in P19 embryonic carcinoma cells, a pluripotent stem cell line [50] , has been reported to enhance the cell proliferation [51] , it would be interesting to further determine the impact of this P2YR subtype in the regulation of proliferation of hESCs. All the genes encoding P2YRs are detectable in the CVPCs (Fig. 4a) , while some of them may not functionally expressed like P2Y 1 and P2Y 11 (BzATP target [52] ). Moreover, based on the different pharmacological profiles of P2YRs [28] , the P2Y 2,4 receptor agonist UTP and the P2Y 6 receptor agonist UDP induce Ca 2+ signals in almost 100 % CVPCs (Fig. 2a, b,  Fig. 3c, d) [15, 39] and the protein expression of IP 3 R2 and IP 3 R3 but not IP 3 R1 are detected in hESCs in this study (Fig. 7a) , it is conceivable to establish the coupling between IP 3 R2/3 and P2YRs in the hESCs using gene manipulation. There are no changes of the P2Y 1 receptor agonist MRS2365-induced concentrationresponse curves in IP 3 R3KD hESCs compared with the vector control and WT hESCs, while IP 3 R2KO significantly decreases the responsive cell proportion to MRS2365 in hESCs, indicating a coupling of IP 3 R2 to the P2Y 1 receptors in the hESCs. Thus, IP 3 R2 but not IP 3 R3 is essential for the Ca 2+ signals mediated by the activation of P2Y 1 receptors in hESCs. Moreover, both IP 3 R2 and IP 3 R3 are involved in the regulation of Ca 2+ responses in the CVPCs, while they differentially contribute to ATP-and UTP-induced Ca 2+ activities (Fig. 7) . The functional switch of IP 3 Rs between hESCs and CVPCs may provide new clues for the dynamics of the intracellular Ca 2+ mobilization in the early differentiating hESCs. Notably, although the gene expression of all IP 3 R subtypes are lower in CVPCs than those in hESCs (Fig. 4a, c) , the nucleotide-mediated Ca 2+ transients are stronger (Fig. 2d, e) . This may additionally due to the enhanced coupling between P2YRs and IP 3 Rs or post-translational modifications on IP 3 Rs [53] . The precise mechanisms underlying the heterogeneity of the Ca 2+ responses and function of IP 3 Rs in hESCs and CVPCs remain to be investigated.
Limitation: although our data are collected from two welldocumented and wildly used cell lines, we cannot exclude the possibility that other hESCs and their derived CVPCs could display different P2Y and IP 3 R expression patterns. Further 
Conclusion
Our results reveal that (i) a functional switch of P2YRs occurs between the hESCs and CVPCs; (ii) Ca 2+ responses to various nucleotides are more sensitive and stronger in the CVPCs than those in the hESCs; (iii) P2Y 1 receptors coupling to IP 3 R2 are the predominant P2YR subtype in hESCs, while P2Y 2,4 receptors coupled to IP 3 R2/3 are enhanced in the CVPCs (Fig. 8) . Our findings suggest that subtype-specific coupling and functional switch of P2YRs and IP 3 Rs might play pivotal roles in the P2R-mediated Ca 2+ signals in hESCs and CVPCs. The findings here would lead to a better understanding of the physiological and pharmacological properties of Ca 2+ signal regulatory receptors in these cells.
